CANF · Can-Fite Biopharma Ltd ADR
United States · RS rating 6 · As of 2026-10-14
| Price | 1.93 USD |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 17 / 7 / 6 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 18 / 16 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +82.1% |
| Market cap (USD) | $6.2M |